{"data":{"id":"us-dc/d.c.-code-48-833.08","jurisdiction":"us-dc","citation":"D.C. Code § 48-833.08","heading":"Report.","body":"The Department shall report to the committee of the Council having jurisdiction over health and human services matters on or before January 1, 2005 and on or before July 1, 2005 on the assessment of fees on manufacturers and labelers of prescription drugs.","path":["Title 48. Foods and Drugs.","Chapter 8A. Affordability of Prescription Drugs — AccessRx Program.","Subchapter III. Full Disclosure of Prescription Drug Marketing Costs."],"source_url":"https://code.dccouncil.gov/us/dc/council/code/sections/48-833.08","current_through":"2026-08-20 (D.C. Law 26-175)","vintage":"","retrieved_at":"2026-08-29T05:44:07Z","sha256":"5c6ad1567f983f7adff7d8c0023cd99f37acc394382e037af58dfff5cf8f5ef4","source_id":"us-dc","stale":false,"prev":"us-dc/d.c.-code-48-833.07","next":"us-dc/d.c.-code-48-833.09"},"notice":"GroundRules: Original legal text. Not legal advice."}